PDCD1 and neoplasm: We demonstrate that SAPCon offers extended half-life, enhancedtumor accumulation, and increased STING activation at tumor sites,resulting in immunological remodeling of the TME that promotes antitumorimmunity and improves response to anti-PD-1 ICB in murine models ofbreast cancer.